Corrona, LLC, a leading provider of real-world observational and syndicated registry data, announced today that it has acquired HealthiVibe, LLC, a leading patient experience company.
HealthiVibe complements and strengthens Corrona’s strong presence in disease registries by providing market-leading expertise in supporting innovative, evidence-based patient engagement initiatives across the product lifecycle. With projects in over 60 countries and more than 90 indications, HealthiVibe also brings valuable global experience and breadth to Corrona.
“I am excited that HealthiVibe is joining the Corrona family,” said Raymond H. Hill, Corrona’s Chairman and CEO. “Our registry expertise and regulatory grade real-world evidence, combined with HealthiVibe’s global background in patient-oriented insights, gives us a unique ability to support our clients.”
“We believe this is a perfect fit for both HealthiVibe and Corrona,” said Abbe Steel, CEO of HealthiVibe. “In response to the FDA’s Patient Focused Drug Development initiative and the 21st Century Cures Act, pharmaceutical companies are investing time and energy in patient insights and real-world evidence. Marrying those two by linking together HealthiVibe’s patient insight background with Corrona’s industry-leading real world evidence data, and drawing on Corrona’s deep relationships with sites and patients, will bring significant value to our clients.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
In addition to her title of CEO of HealthiVibe, Abbe will also be taking on the newly created role of Chief Patient Officer at Corrona.
Source: Prnews Wire
